Details
Stereochemistry | UNKNOWN |
Molecular Formula | C18H31N3O3 |
Molecular Weight | 337.457 |
Optical Activity | ( - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)NCC(O)COC1=CC=C(CCNC(=O)NC(C)C)C=C1
InChI
InChIKey=PKWZWSXSCKVUJB-UHFFFAOYSA-N
InChI=1S/C18H31N3O3/c1-13(2)20-11-16(22)12-24-17-7-5-15(6-8-17)9-10-19-18(23)21-14(3)4/h5-8,13-14,16,20,22H,9-12H2,1-4H3,(H2,19,21,23)
Molecular Formula | C18H31N3O3 |
Molecular Weight | 337.457 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6129091
Intravenous pafenolol (5 mg and 7.5 mg), metoprolol (15 mg), and saline were given double-blind at random and thereafter four increasing doses of terbutaline were given intravenously to seven asthmatic patients with reproducible reversibility of airways obstruction.
Route of Administration:
Intravenous
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:19:53 GMT 2023
by
admin
on
Sat Dec 16 10:19:53 GMT 2023
|
Record UNII |
QW8T7NK8X6
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
178968-84-8
Created by
admin on Sat Dec 16 10:19:54 GMT 2023 , Edited by admin on Sat Dec 16 10:19:54 GMT 2023
|
PRIMARY | |||
|
QW8T7NK8X6
Created by
admin on Sat Dec 16 10:19:54 GMT 2023 , Edited by admin on Sat Dec 16 10:19:54 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
RACEMATE -> ENANTIOMER | |||
|
ENANTIOMER -> ENANTIOMER |
|